Dynatronics Corporation Gains Approval Of Its Thermostim Probe Patent

SALT LAKE CITY, Aug. 12, 2015 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced its patent for "Systems and Methods for Providing a Thermo-electro-stimulation Probe Device" (US Patent No. 9,084,665) has been granted by the U.S. Patent and Trademark Office.  This technology is incorporated in the company's ThermoStim Probe used in the delivery of therapeutic treatments.

The innovative ThermoStim Probe delivers thermal (hot and cold) therapy and/or electrotherapy in a targeted, attended treatment.  Over the past year, this novel technology has become popular among physical therapists, sports medicine practitioners and athletic trainers for increasing local blood circulation, reducing muscle spasm and relieving pain in patients and athletes.

"The unique advantages of the ThermoStim Probe, which include reduced treatment time with the simultaneous delivery of three distinct treatments and greater ease of use compared to conventional methods, should make this important new tool a 'must have' for clinicians," said Larry K. Beardall, Executive Vice President of Sales and Marketing.  "Gaining a patent on this new technology distances us from competitors and will provide us a proprietary advantage for many years to come."

"Because the probe is operated from the control console of the SolarisPlus units, demand for SolarisPlus units has risen commensurate with the demand for the ThermoStim Probe," added Beardall.

"We believe the unique advantages of the ThermoStim Probe, together with the expansion of our distribution channels both domestically and internationally, will help drive sales of our therapeutic device products going forward," he concluded.

About Dynatronics Corporation:

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, and other related medical markets. More information regarding Dynatronics is available at www.dynatronics.com.

Safe Harbor Notification

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dynatronics-gains-approval-of-its-thermostim-probe-patent-300127619.html

SOURCE Dynatronics Corporation